Zhejiang Orient Gene Biotech Co., Ltd

SHSE:688298 Stock Report

Market Cap: CN¥3.8b

Zhejiang Orient Gene Biotech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xiaoliang Fang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure7.5yrs

Recent management updates

Recent updates

Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Weighed On By Its Debt Load?

Aug 20
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Weighed On By Its Debt Load?

Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) A Risky Investment?

Apr 30
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) A Risky Investment?

CEO

Xiaoliang Fang (67 yo)

7.5yrs

Tenure

CN¥1,152,900

Compensation

Mr. Xiaoliang Fang is GM & Director of Zhejiang Orient Gene Biotech Co., Ltd. from April 18, 2017.

Board Members

NamePositionTenureCompensationOwnership
Xiaoliang Fang
GM & Director7.5yrsCN¥1.15mno data
Xiaoping Han
Independent Director7.5yrsCN¥100.00kno data
Jianqiu Fang
Chairman7.5yrsCN¥1.25mno data
Wei Lin
Independent Director7.5yrsCN¥100.00kno data
Haiying Feng
Chairman of the Board of Supervisors7.5yrsno data0.13%
CN¥ 4.8m

7.5yrs

Average Tenure

59yo

Average Age

Experienced Board: 688298's board of directors are considered experienced (7.5 years average tenure).